Magnetic resonance imaging and ultrasound examination in preoperative pelvic staging of early‐stage cervical cancer: post‐hoc analysis of SENTIX study
Ultrasound in Obstetrics & Gynecology · 2025
DOI: 10.1002/uog.29205 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2025. Verfasst von D Cibula und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Magnetic Resonance Imaging. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Youth and Sports of the Czech Republic, Všeobecná Fakultní Nemocnice v Praze, Czech Health Research Council.
Abstract (Originalsprache)
Objectives
SENTIX was a prospective, single‐arm, international multicenter study that evaluated sentinel lymph node biopsy without pelvic lymph node dissection in patients with early‐stage cervical cancer. We aimed to evaluate the concordance between preoperative imaging modalities (magnetic resonance imaging (MRI) and ultrasound) and final pathology in the clinical staging of early‐stage cervical cancer by post‐hoc analysis of the SENTIX study data.
Methods
In total, 47 sites across 18 countries participated in the SENTIX study. Patients with Stage IA1/lymphovascular space invasion‐positive to IB2 (International Federation of Gynecology and Obstetrics (FIGO) classification (2018)) cervical cancer, with usual histological types and no suspicious lymph nodes on imaging, were prospectively enrolled between May 2016 and October 2020. Preoperative pelvic clinical staging on either pelvic MRI or ultrasound examination was mandatory. Tumor size discrepancy (< 10 mm vs ≥ 10 mm) between imaging and pathology, as well as the negative predictive value (NPV) of MRI and ultrasound for parametrial involvement and lymph node macrometastasis, were analyzed.
Results
Among 690 eligible prospectively enrolled patients, MRI and ultrasound were used as the staging imaging modality in 322 (46.7%) and 298 (43.2%) patients, respectively. A discrepancy of tumor size ≥ 10 mm was reported between ultrasound and final pathology in 39/298 (13.1%) patients and between MRI and pathology in 53/322 (16.5%), with no significant difference in the accuracy of tumor measurement between the two imaging modalities. The NPV of ultrasound in assessing parametrial infiltration and lymph node involvement was 97.0% (95% CI, 0.95–0.99%) and 94.0% (95% CI, 0.91–0.97%), respectively, and that of MRI was 95.3% (95% CI, 0.93–0.98%) and 94.1% (95% CI, 0.92–0.97%), respectively, with no significant differences between the parameters. Ultrasound and MRI were comparable regarding the tumor size measurement ( P = 0.452), failure to detect parametrial involvement ( P = 0.624) and failure to detect macrometastases in sentinel lymph node ( P = 0.876).
Conclusions
Pelvic ultrasound examination and MRI had similar concordance with histology in the assessment of tumor size and of parametrial and lymph node invasion in early‐stage cervical cancer. Ultrasound examination should be considered part of preoperative pelvic clinical staging in early‐stage cervical cancer, especially in limited‐resource regions where MRI is unavailable. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- Department of Gynecology, Asklepios Clinic Hamburg Altona, Berlin, Germany.
- Department of Gynecology, DRK Klinik Berlin Westend, Berlin, Germany.
- Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Czech Republic.
ORCID-Profile: D Cibula
Förderung
- Ministry of Education, Youth and Sports of the Czech Republic
- Všeobecná Fakultní Nemocnice v Praze
- Czech Health Research Council
- Univerzita Karlova v Praze, Cooperatio - Maternal and Childhood Care; Neonat
- Agentura Pro Zdravotnický Výzkum České Republiky
- Univerzita Karlova v Praze
Zitieren
APA
Cibula, D., Köhler, C., Jarkovský, J., Kocián, R., Dundr, P., Klát, J., Zapardiel, I., Landoni, F., Frühauf, F., Fischbach, R., Borčinová, M., & Fischerová, D. (2025). Magnetic resonance imaging and ultrasound examination in preoperative pelvic staging of early‐stage cervical cancer: post‐hoc analysis of SENTIX study. Ultrasound in Obstetrics & Gynecology. https://doi.org/10.1002/uog.29205
Vancouver
Cibula D, Köhler C, Jarkovský J, Kocián R, Dundr P, Klát J, et al. Magnetic resonance imaging and ultrasound examination in preoperative pelvic staging of early‐stage cervical cancer: post‐hoc analysis of SENTIX study. Ultrasound in Obstetrics & Gynecology. 2025. doi:10.1002/uog.29205
BibTeX
@article{Cibula2025,
author = {Cibula, D and Köhler, C and Jarkovský, J and Kocián, R and Dundr, P and Klát, J and Zapardiel, I and Landoni, F and Frühauf, F and Fischbach, R and Borčinová, M and Fischerová, D},
title = {Magnetic resonance imaging and ultrasound examination in preoperative pelvic staging of early‐stage cervical cancer: post‐hoc analysis of SENTIX study},
journal = {Ultrasound in Obstetrics & Gynecology},
year = {2025},
doi = {10.1002/uog.29205}
}
EUVIMED